News

Test images

The $18 million acquisition of ClickFind significantly increases customer base and provides the most advanced and extensive eClinical technology platform in the market.

Images

images

Agreement represents a working relationship that will involve joint marketing efforts and a mutual contracting of complementary products and services.

Partnership expands depth and breadth of clinical services

Tools for Clinical Trials Professionals

Authors comment on Kirby et al.'s remedies for placebo response.

United BioSource Corporation (UBC) today announced the acquisition of MetaWorks, Inc., a leading provider of systematic reviews and meta-analyses to inform development, marketing, and regulatory decision-making regarding health care products and services.

ArisGlobal, a leading provider of pharmacovigilance software solutions, announces the general availability of SafetyMart, a comprehensive data mining and signal detection application which facilitates in-depth data analysis and proactive benefit/risk assessment of drug safety data.

PRISYM Medica 5 software features RFID capability and ensures compliance with latest FDA regulations

Closing Thoughts on the state of clinical trials in India today.

Tools for Clinical Trials Professionals

Mr. Nils Behrndt, Deputy Head of Unit, Directorate F2 (Pharmaceuticals), DG Enterprise and Industry, European Commission has agreed to join the TOPRA Advisory Council.

Download the most current BPA statement...

The collaboration is extended by five years, with a termination option after the first collaboration year.

Despite accuracy and security concerns, biometrics are gaining in popularity.

Landmark contract signed in Munich.

At Amsterdam Airport delegates representing the local CRO associations from the Netherlands, Germany, Czech Republic, France, Spain, Italy and United Kingdom were represented for the inaugural meeting of the European CRO Federation (EUCROF).

Merck Sharp & Dohme (MSD) has launched a campaign aimed at raising patients' awareness of the potential risks of counterfeit medicines and the danger of buying prescription-only drugs from unregulated websites.

The purpose of the agreement, signed in August 2003, is to jointly evaluate selected proprietary NicOx nitric oxide-donating compounds in an undisclosed therapeutic area.

Tools for Clinical Trials Professionals

Central laboratories are realizing significant cost and time efficiencies by using standardized data.

Novartis to Acquire Outstanding 58 Percent of Chiron Shares for $45.00 Per Share in Cash

The Convergence of Data: Healthcare and Life Sciences

The Convergence of Data: Healthcare and Life Sciences

The New England Journal of Medicine published the results from a National Institute of Mental Health-funded study titled Clinical Antipsychotic Trial of Intervention Effectiveness – Schizophrenia (CATIE–SZ). ICTI is proud to reveal that the data for this study, conducted with 1493 subjects from 57 clinical sites in 24 states, was collected using an early version of ICTI’s iTrial EDC software.

The pace of industry consolidation shows no signs of slowing down, and more mergers seem inevitable. Who will be the biggest players in another 10 years? Which companies look set to be swallowed up? A leading pharmaceutical analyst and former investment banker made his predictions at the Networking Dinner of the ACT European Summit.